Research Synthesis: Glynac — full paper

Researka accepted publication: 104ef0f2-3c97-42e2-8507-9b6ddf7ebf49 Source submission: 2cf6aad4-0f57-4c85-a6ea-cdaa7c59098f This paper synthesizes glynac as an aging-related intervention across 16 included source papers and 916 high-confidence extracted claims. The evidence profile contains no sources classified primarily as direct clinical evidence, 8 adjacent clinical sources, and 3 mechanistic or model-system sources, with 17 cross-study disagreements across the evidence base. Positive study-level signals are summarized in the deficiency prevalence outcome class, null signals in the deficiency prevalence, contextual adjacent evidence and immune outcome classes, and negative signals in no dominant outcome class. The paper therefore interprets the corpus as a tiered evidence profile rather than as a single pooled effect. The conclusion is that glynac should be treated as a bounded geroscience hypothesis: the retained clinical and adjacent evidence profile defines the scope for targeted testing, while mixed and null findings limit any unqualified anti-aging claim.